NALOXONE AGUETTANT

Medicinal product

(Invented) name

NALOXONE AGUETTANT

Active substance (s)

Naloksono hidrochloridas

Strength

400 µg/ml

Pharmaceutical form

injekcinis ar infuzinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

V03AB15, Naloxone

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2024-12-30

Date of renewal

Documents

2295_NALOXONE AGUETTANT 400mcg-ml_inj_inf_tirp_PZ_2024-12-30.docx

2295_NALOXONE AGUETTANT 400mcg-ml_inj_inf_tirp_PL_2024-12-30.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Ampulėje (1 ml) yra:	1 ml
Naloksono hidrochloridas	400 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116074	102175	1102175	ampulė	1 ml N10		Receptinis	LT/L/24/2295/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2024-12-30	Registruotas